Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: sam who wrote (3762)	2/7/1998 2:23:00 PM
From: Henry Niman	Respond to of 6136

sam, I've revised the Links to Ligand page at home.att.net to include the links to an excerpt from next weeks Barron's which discusses the proposed GLX/SBH merger. Under LGND alliances I have put the link in the GLX and SBH table (the link is called "Made in Heaven NOT"). The article briefly talks about up and coming approaches to treat AIDS. I'm also working on a Biotech Boom table. So far it's mostly about LGND, but I will adding links to indications that Biotechs have started to make a move. Sorry about my timing on AGPH. The fat deposit news caught my eye and I was curious about what was being said so I threw in a couple of articles and a comment or two after doing a quick catch up. Many of the times my comments are viewed somewhat unfavorably, but generally I'm looking for clarifications and expect info from some of the regulars who read or post here.